europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

22/03/2021
PRESS RELEASE

EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe

The National Associations Council of EuropaBio is pleased to launch its 2021 Summit ‘Building on Biotechnology: From vaccines to economic Growth for Europe’ being hosted on May 10.

This inaugural Summit for the National Associations Council (NAC) will address how national priorities and synergies should be used to create an economic recovery pathway for Europe through biotechnology.

The Covid crisis has created many precedents for the faster delivery of biotechnologies to market, and Europe now has a significant opportunity to continue this momentum across all sectors and ensure a competitive global position. Initiatives such as the European Health Emergency Preparedness and Response Authority (HERA), plus the Industrial and Circular Economy Strategies are all enablers for biotechnology and will be addressed in the Summit.

The NAC Summit, jointly hosted with Portugal’s P-BIO in line with the current European Council Presidency, addresses its mission in two key sessions:

Innovation and delivery for vaccine across countries and value chains Large companies SMEs and universities active in vaccine development will present how they were able to bring the vaccines to patient in unprecedented speed. They will share the enabling factors behind their collaboration and development, including partnering, finance, policy and regulation.

Vaccine learning – Driving economic delivery with biotechnology SME presentations will demonstrate potential for the future, followed by a panel discussion with National Associations where priorities will be agreed for effective and impactful mobilisation of national resources to achieve a competitive Europe.

The Summit will develop and publish a position for EuropaBio’s National Associations and use this as a roadmap in the Council’s work in supporting European development through national actions and synergies.

Dr Claire Skentelbery, Director General of EuropaBio commented “Europe has a powerful engine to build competitiveness, through its Member and partner countries on the continent. This Summit reflects priorities and capabilities of countries of all sizes in Europe and helps to ensure that we all progress together”.

Filipa Sacadura, Secretary General of P-BIO added “Portugal’s biotech sector is actively involved in vaccine development within global partnerships and this Summit reflects our own national priorities to further build on the economic power of biotechnology in the future”.

REGISTER NOW!

REGISTER HERE


REGISTER HERE
NAC Summit 2

EuropaBio and P-BIO launch the National Associations Council Summit 2021


Download
2021_04_N_PR_EuropaBio-P-BIO-Launch-NAC-SummitDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
17/01/2023

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member